Artis BioSolutions News and Activities

Acquisition, funding and merger involving Artis BioSolutions.

• Artis BioSolutions has announced the acquisition of Syngoi Technologies  (posted on January 15 2026).

View the org chart displaying its 5 main executives

Most searched biographies at Artis BioSolutions

• Brian Neel, Chief Executive Officer
• Kate Broderick, Chief Scientific Innovation Officer
• Mike Houston, Chief Scientific Officer

Popular executive movements at Artis BioSolutions

• Kate Broderick has joined the company as Chief Scientific Innovation Officer  (posted on February 18 2026).

Create your alert
to follow the executive moves at Artis BioSolutions.

Artis BioSolutions has 2,425 competitors including Lonza (Switzerland), Vertex Pharmaceuticals (United States (USA)) and Eurofins (Luxembourg).

Popular M&A news in Biotechnology

• Chemomab and Scipher Medicine have announced they will merge  (posted on July 13 2026)..
• Apnimed has filed its IPO. Its stock ticker will be APMD. (posted on July 13 2026).
• The new name of EG 427 is Cyllene Therapeutics. (posted on July 10 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Carl Gordon - Director at Odyssey Therapeutics
• Jan Van de Winkel - President and Chief Executive Officer at Genmab

Learn more about the Biotechnology industry

Press releases by Artis BioSolutions

Social media about Artis BioSolutions

• Artis BioSolutions on Wikipedia, Google News & Yahoo Finance
• Artis BioSolutions on LinkedIn, X (Twitter) & YouTube